[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$asnd Graphic](https://lunarcrush.com/gi/w:26/t:$asnd.png) $asnd

Ascendis Pharma ($ASND) sees positive analyst ratings and strong clinical data, but faces competition concerns.  The stock is trending with high engagement and mentions in stock recommendations.

### About $asnd
ASND refers to Ascendis Pharma, a biopharmaceutical company.  

### Engagements: XXXXX [#](/topic/$asnd/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$asnd/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$asnd/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Month**: XXXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-05-16  
**1-Year Low**: XXX on 2025-06-14  

| Social Network | X     | YouTube |
| -------------- | -     | ------- |
| Engagements    | XXXXX | XX      |
  

  
  
### Mentions: XX [#](/topic/$asnd/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$asnd/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$asnd/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX -XX%  
**1 Month**: XXX +308%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-04-27  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | X       |
  

  
  
### Creators: XX [#](/topic/$asnd/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$asnd/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$asnd/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $asnd in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XX -XX%  
**1 Month**: XXX +808%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-04-27  

The most influential creators that mention $asnd in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XXXXX       |

[View More](/list/creators/$asnd/100)
  
  
### Sentiment: XX% [#](/topic/$asnd/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$asnd/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$asnd/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% +19%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-05-19  

**Most Supportive Themes**
- **Positive Clinical Data and Analyst Ratings:** (60%) Positive feedback on the effectiveness of the treatment and analyst ratings are driving positive sentiment.
- **Stock Recommendations and Catalysts:** (30%) Mentions in stock recommendations and discussions about potential positive catalysts are also supportive.
  
**Most Critical Themes**
- **Competition and Side Effects:** (10%)  Concerns about potential side effects and the impact of competing treatments are being discussed.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | X        | X% |
| YouTube | X        | X%  | X       | X%  | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $asnd in the last XX hours

[Akropolis (AKRO)](/topic/$akro)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[GSK plc (GSK)](/topic/$gsk)
[SuperRare (RARE)](/topic/$rare)
[Marblex (MBX)](/topic/$mbx)
[BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn)
[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Linde PLC (LIN)](/topic/$lin)

**Top topics mentioned**
In the posts about $asnd in the last XX hours

[$repl](/topic/$repl), [$rhhby](/topic/$rhhby), [aes](/topic/aes), [$akro](/topic/$akro), [$veon](/topic/$veon), [$regn](/topic/$regn), [$kalv](/topic/$kalv), [$gsk](/topic/$gsk), [manat](/topic/manat), [stocks](/topic/stocks), [qqq](/topic/qqq), [spx](/topic/spx), [abbv](/topic/abbv), [$qntm](/topic/$qntm), [$legn](/topic/$legn), [telo](/topic/telo), [pltr](/topic/pltr), [$rare](/topic/$rare), [mbx](/topic/mbx), [$mbx](/topic/$mbx), [$argx](/topic/$argx), [$bmrn](/topic/$bmrn), [$alny](/topic/$alny), [$nbix](/topic/$nbix), [$hrmy](/topic/$hrmy), [meta](/topic/meta), [hood](/topic/hood), [$xbi](/topic/$xbi), [stocks healthcare](/topic/stocks-healthcare), [$lyel](/topic/$lyel), [$vrna](/topic/$vrna), [$arqt](/topic/$arqt), [$tars](/topic/$tars), [$dcth](/topic/$dcth), [$rckt](/topic/$rckt), [nvda](/topic/nvda), [$amrx](/topic/$amrx), [$hcm](/topic/$hcm), [$iron](/topic/$iron), [grrr](/topic/grrr), [$ntcl](/topic/$ntcl), [insp](/topic/insp), [asts](/topic/asts), [$mdvn](/topic/$mdvn), [pfe](/topic/pfe), [dtc](/topic/dtc), [$knsa](/topic/$knsa), [jnj](/topic/jnj), [apld](/topic/apld), [approved](/topic/approved), [$grfs](/topic/$grfs), [stockmarket](/topic/stockmarket), [spy](/topic/spy), [$crvo](/topic/$crvo), [lin](/topic/lin), [sqns](/topic/sqns), [$nby](/topic/$nby), [$cmpo](/topic/$cmpo), [$lin](/topic/$lin), [mira](/topic/mira), [amzn](/topic/amzn), [$ngne](/topic/$ngne), [$tecx](/topic/$tecx), [$kura](/topic/$kura), [$oric](/topic/$oric), [$apls](/topic/$apls), [cort](/topic/cort), [$tvtx](/topic/$tvtx), [$arkg](/topic/$arkg), [$sbio](/topic/$sbio), [doc](/topic/doc), [plag](/topic/plag), [srm](/topic/srm), [op](/topic/op), [$weav](/topic/$weav), [$lab](/topic/$lab), [ogn](/topic/ogn), [$kros](/topic/$kros), [$meip](/topic/$meip), [$weth](/topic/$weth), [$wct](/topic/$wct), [$ysxt](/topic/$ysxt), [$asmb](/topic/$asmb), [$zyme](/topic/$zyme), [$nvs](/topic/$nvs), [longterm](/topic/longterm), [$bcax](/topic/$bcax), [$rxst](/topic/$rxst), [$mlys](/topic/$mlys), [$tyra](/topic/$tyra), [wsj](/topic/wsj), [$sana](/topic/$sana), [gden](/topic/gden), [btcm](/topic/btcm), [$prm](/topic/$prm), [$fulc](/topic/$fulc), [$byrn](/topic/$byrn), [$aubn](/topic/$aubn), [$bctxw](/topic/$bctxw), [$rgls](/topic/$rgls)

### Top Social Posts [#](/topic/$asnd/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I made $76k today buying stocks on @Yzq_hpp775 's advice.💐🌈 And it worked. Awesome $DHAI $GCTK $APLM $DTC $TELO $CYCC $BZAI $STEM $LMFA $CELU $UAVS $OPEN $CARV $FITBO $AES $SGMT $PLTR $CLIR $SGRY $FA $VTMX $FLDDW $FARM $ASND $MXC"  
[@JamesRivas42482](/creator/x/JamesRivas42482) on [X](/post/tweet/1946450312304423139) 2025-07-19 06:01:32 UTC X followers, X engagements


"I made $76k today buying stocks on @Yzq_hpp775 's advice.🌻🌻 And it worked. Awesome $DHAI $GCTK $APLM $DTC $TELO $CYCC $BZAI $STEM $LMFA $CELU $UAVS $OPEN $CARV $HCA $WTBA $GWH $NPACU $PWR $ACCS $ASND $TLYS $NVVE $LSEA $ASPI $KNSA"  
[@McbrideKim25749](/creator/x/McbrideKim25749) on [X](/post/tweet/1946323068701360165) 2025-07-18 21:35:55 UTC X followers, XX engagements


"@Analyst_Gary publishes stock recommendations every day I followed the purchases and made $43200 in a month. Thank you. $MIRA $AIRE $NCL $AEBI $XPOF $MINM $MDBH $ZBAO $ICU $SCWO $LIMN $TELO $DDOG $SHFS $HUNB $SCWO $TRIP $YGMZ $YSXT $WCT $ASND $WETH $MEIP"  
[@freeman_besum](/creator/x/freeman_besum) on [X](/post/tweet/1946319412912435653) 2025-07-18 21:21:23 UTC X followers, XX engagements


"#ThinkSabio #Trendingstock $SPX $SPY $XBI $QQQ $IWM #Markets #StockMarket #Stocks #Trending @BiO Upcoming Catalyst of Next Week 20-27 2025: July 22: $ONCY $REPL July 23: $GSK July 27: $INMB $ASND $CRVO July 28: $APLS"  
[@thinksabio](/creator/x/thinksabio) on [X](/post/tweet/1946252454691311767) 2025-07-18 16:55:19 UTC XXX followers, XXX engagements